Zylox-Tonbridge Medical Technology Co., Ltd.

SEHK:2190 Voorraadrapport

Marktkapitalisatie: HK$3.7b

Zylox-Tonbridge Medical Technology Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Zylox-Tonbridge Medical Technology has been growing earnings at an average annual rate of 16.5%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 51.5% per year. Zylox-Tonbridge Medical Technology's return on equity is 0.8%, and it has net margins of 3.9%.

Belangrijke informatie

16.5%

Groei van de winst

27.7%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie13.7%
Inkomstengroei51.5%
Rendement op eigen vermogen0.8%
Nettomarge3.9%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Sep 27
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Recent updates

Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Oct 02
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Sep 27
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Jan 18
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

Sep 21
Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

Aug 03
There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

Mar 08
Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jan 19
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Jul 06
Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Oct 05
Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Opbrengsten en kosten

Hoe Zylox-Tonbridge Medical Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SEHK:2190 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2466426276232
31 Mar 24596-27277246
31 Dec 23528-79278261
30 Sep 23470-101275266
30 Jun 23411-124272270
31 Mar 23373-119261252
31 Dec 22334-114249233
30 Sep 22297-135234223
30 Jun 22259-155219213
31 Mar 22219-178207191
31 Dec 21178-200196168
30 Sep 21137-168158131
30 Jun 2197-13511994
31 Mar 2162-1188583
31 Dec 2028-1005172
31 Dec 195-672453

Kwaliteitswinsten: 2190 has a large one-off loss of CN¥19.3M impacting its last 12 months of financial results to 30th June, 2024.

Groeiende winstmarge: 2190 became profitable in the past.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 2190 has become profitable over the past 5 years, growing earnings by 16.5% per year.

Versnelling van de groei: 2190 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Winst versus industrie: 2190 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).


Rendement op eigen vermogen

Hoge ROE: 2190's Return on Equity (0.8%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden